investor.enzon.comInvestor Relations | Enzon Pharmaceuticals
investor.enzon.com Profile
Investor.enzon.com is a subdomain of enzon.com, which was created on 1996-02-18,making it 28 years ago.
Discover investor.enzon.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
investor.enzon.com Information
| HomePage size: 25.193 KB |
| Page Load Time: 0.820378 Seconds |
| Website IP Address: 23.52.0.114 |
investor.enzon.com Similar Website
| Masonite International Corp. - Investor Relations - Investor Relations |
| Block, Inc. (SQ) Investor Relations - Investor Relations |
| Gen Investor Relations - Investor Relations |
| MindChamps PreSchool Limited - Investor Relations: Investor Relations |
| Home - Ayala Land Investor Relations : Ayala Land Investor Relations |
| Universal Technical Institute's Investor Relations - UTI Investor Relations |
| Ameriprise Financial Investor Relations | Investor Relations |
| Meridian Bank Investor Relations - Meridian Bank Investor Relations |
| Armstrong World Industries Investor Relations | Armstrong Flooring Investor Relations |
| Walmart Investor Relations - Investor Relations |
| Alphabet Investor Relations - Investor Relations - Alphabet |
| Investor Relations | Jacobs - Investor Relations |
investor.enzon.com PopUrls
| Enzon Pharmaceuticals: Investor Relations https://investor.enzon.com/ |
| Press Releases | Investor Relations | Enzon Pharmaceuticals https://investor.enzon.com/press-releases |
| SEC Filings https://investor.enzon.com/sec-filings |
| Downloads https://investor.enzon.com/downloads |
| Corporate Governance https://investor.enzon.com/corporate-governance |
| Contact Us https://investor.enzon.com/contact-us |
| SEC Filing | Enzon Pharmaceuticals https://investor.enzon.com/node/15576/html |
| SEC Filing | Enzon Pharmaceuticals https://investor.enzon.com/node/14696/html |
| SEC Filing https://investor.enzon.com/node/11346/html |
| Stock Information | Investor Relations | Enzon Pharmaceuticals https://investor.enzon.com/stock-information/ |
| Stock Quote & Chart | Enzon Pharmaceuticals https://investor.enzon.com/stock-information/stock-quote-chart |
| Historic Stock Lookup | Enzon Pharmaceuticals https://investor.enzon.com/stock-information/historic-stock-lookup |
| Dividends & Splits | Enzon Pharmaceuticals https://investor.enzon.com/stock-information/dividends-splits |
| Enzon Pharmaceuticals Anticipated Rights Offering to Existing ... https://investor.enzon.com/news-releases/news-release-details/enzon-pharmaceuticals-anticipated-rights-offering-existing |
| Enzon Pharmaceuticals Announces Key Dates for Rights Offering https://investor.enzon.com/news-releases/news-release-details/enzon-pharmaceuticals-announces-key-dates-rights-offering |
investor.enzon.com Httpheader
| Accept-Ranges: bytes |
| Content-Encoding: gzip |
| Content-Language: en |
| Content-Security-Policy: report-uri //report-csp-violation |
| Content-Type: text/html; charset=UTF-8 |
| device: desktop |
| ETag: "1581605021" |
| From-Origin: same |
| Last-Modified: Thu, 13 Feb 2020 14:43:41 GMT |
| Link: http://investor.enzon.com/; rel="shortlink", http://investor.enzon.com/; rel="canonical", https://investor.enzon.com/investor-relations; rel="alternate"; hreflang="en", https://investor.enzon.com/investor-relations; rel="revision" |
| Server: nginx |
| X-Age: 0 |
| X-Content-Security-Policy: report-uri //report-csp-violation |
| X-Content-Type-Options: nosniff |
| X-Drupal-Dynamic-Cache: UNCACHEABLE |
| X-Frame-Options: SAMEORIGIN |
| X-Generator: Drupal 8 (https://www.drupal.org) |
| X-Request-ID: v-3a605f7a-4e6f-11ea-ab8a-5736289fb213 |
| X-UA-Compatible: IE=edge |
| X-WebKit-CSP: report-uri //report-csp-violation |
| X-XSS-Protection: 1; mode=block |
| X-EdgeConnect-MidMile-RTT: 1, 15 |
| X-EdgeConnect-Origin-MEX-Latency: 328, 328 |
| X-Akamai-Transformed: 9 7339 0 pmb=mRUM,1 |
| Cache-Control: public, max-age=0, s-maxage=1800 |
| Expires: Thu, 13 Feb 2020 14:43:41 GMT |
| Date: Thu, 13 Feb 2020 14:43:41 GMT |
| Content-Length: 7770 |
| Connection: keep-alive |
| Vary: Accept-Encoding |
| Set-Cookie: SimpleSAMLSessionID=4b994edd25ca363163341f0e739c7ed8; path=/; secure; HttpOnly, DrupalVisitorMobile=0; path=/ |
| Strict-Transport-Security: max-age=15768000 ; preload |
investor.enzon.com Meta Info
| charset="utf-8"/ |
| content="Investor Relations | Enzon Pharmaceuticals" name="title"/ |
| content="Enzon Pharmaceuticals" property="og:site_name"/ |
| content="website" property="og:type"/ |
| content="no-referrer" name="referrer"/ |
| content="Drupal 8 (https://www.drupal.org)" name="Generator"/ |
| content="width" name="MobileOptimized"/ |
| content="true" name="HandheldFriendly"/ |
| content="width=device-width, initial-scale=1.0" name="viewport"/ |
| content="IE=edge,chrome=1" http-equiv="X-UA-Compatible"/ |
investor.enzon.com Ip Information
| Ip Country: United States |
| City Name: Los Angeles |
| Latitude: 34.0544 |
| Longitude: -118.2441 |
investor.enzon.com Html To Plain Text
ENZON ROYALTY PRODUCTS INVESTORS & MEDIA Investor Relations Press Releases Corporate Governance SEC Filings Stock Quote Stock Lookup Contact Us CONTACT US Request Information Email Alerts Download Library RSS News Feeds Shareholder Tools Investor Relations Enzon Pharmaceuticals, Inc. manages its sources of royalty revenues from existing licensing arrangements with other companies primarily related to sales of certain drug products that utilize our proprietary technology. Stock Quote: ENZN Exchnage OT Price Change Volume Feb 13, 2020 9:43 AM EST. 15 minute delayed data Provided by NASDAQ ©2017 Enzon Pharmaceuticals, Inc., All Rights...
investor.enzon.com Whois
Domain Name: ENZON.COM Registry Domain ID: 1091851_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2024-01-21T14:49:16Z Creation Date: 1996-02-18T05:00:00Z Registry Expiry Date: 2027-02-19T05:00:00Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS0.DNSMADEEASY.COM Name Server: NS1.DNSMADEEASY.COM Name Server: NS2.DNSMADEEASY.COM Name Server: NS3.DNSMADEEASY.COM Name Server: NS4.DNSMADEEASY.COM DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T19:31:44Z <<<